This study shows improved microbial assessments in ready-to-eat meat using viability differentiation with PMA, indicating better identification of spoilage organisms.
Aims The objective of this study was to evaluate 16S rRNA gene sequencing with viability differentiation as a diagnostic tool to assess microbial contamination during ready-to-eat (RTE) meat manufacturing. Methods and Results Product samples were collected from a commercial RTE meat manufacturing facility raw (n = 45), after cooking, chilling, holding, staging, slicing, and packaging (n = 27, N = 207). After homogenization, samples were split and either not treatment (Control) or treated with propidium monoazide (PMA). DNA was subsequently extracted, sequenced, and bioinformatically analyzed. Statistical significance of α- and β-diversity metrics were determined using ANOVA and ADONIS, respectively, and differentially abundant taxonomic groups were identified using ANCOM (P ≤ 0.05, Q ≤ 0.05). PMA treated samples exhibited a less rich microbial community, but the impact of PMA treatment varied by location. Thermal processing had a similar effect on the microbial community of both treatment groups; however, in PMA treated samples a second shift was observed after slicing along with an increase in the relative abundance of Lactobacillus. The presence of this microorganisms was further confirmed through the culture-based identification of Latilactobacillus sakei. Conclusions PMA treatment improved the resolution of 16S rRNA gene sequencing, allowing for better identification of viable spoilage contaminants during RTE meat manufacturing.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: